HealthTech Integrates is a one-day event convening technology, diagnostics, devices, and therapeutics organizations, along with clinicians and regulators, to provide an esteemed platform for discussing the major challenges impacting the HealthTech sector. The conference focuses on addressing the needs of the HealthTech community to overcome the obstacles necessary to transform diagnostics and devices in healthcare.
AI and Machine Learning are transforming diagnostics, improving diagnostic accuracy, personalising treatment plans, and enabling proactive care. How can we ensure the effective integration of AI in healthcare, harnessing these technologies for enhanced disease detection, tailored treatments – and ultimately – better, faster care?
Mills & Reeve
Partner and Head of Life Sciences
James heads Mills & Reeve’s multi-disciplinary life sciences practice. He supports businesses across the full product lifecycle, from start-up to commercialisation.
A key focus of his work is supporting clients on strategic contracting covering technology / IP in and out- licensing transactions, research collaborations, clinical trial agreements and long term partnering agreements. James also advises on sector regulation including pharma and medical device regulation, market access, borderline products, advertising and clinical trials.
Neuronostics
Managing Director
As managing director of Neuronostics Ltd, I am the strategic lead for the company with overall responsibility for leading the development and commercialisation of its clinical decision support systems and at-home monitoring tools. The company has recently moved its HQ to Bristol, where we are fortunate to be part of the SetSquared community. The potential of our products has been recognised regionally (Medilink SW StartUp award 2020, TechSW Best Healthcare 2020, Medilink SW Innovation award 2021) and nationally (Medilink UK StartUp 2020). To date we have secured over £1.5M in non-dilutive funding and £500K in dilutive funding to support the company’s growth.
PA Consulting
Managing Consultant
Gloria is part of PA’s team of Healthcare and Life Sciences Consultants. She has a strong background in bioprocessing and 10 years of international industry experience in developing operational capabilities in cell and gene therapies and commercialising regenerative medicine products.
Gloria has published 25 peer-reviewed articles and book chapters in areas including regenerative medicine, bioprocessing and digital health. Specifically, she has published articles on impact of fast-track designations, decision lifecycle, supply chains and capacity planning decisions on advanced therapies commercialisation.
Gloria holds a DPhil in biomedical engineering from the University of Oxford.
CPI
Director of Health Tech
Rahul is the director of Health Tech business at CPI, which offers end to end innovation development services. We work with mature companies and start-ups to develop transformative ideas into commercial products.
He has 15+ years of global experience working for Johnson & Johnson and Unilever. At J&J, Rahul led growth of medical devices within cardiovascular across EMEA. He worked on the adoption of innovative mental health and infectious pharmaceutical treatments in the NHS.
Recently, at Medicspot, a digital health company, Rahul has been working as the Chief Commercial Officer. Medicspot is creating digital technologies that will improve access and efficiencies within primary healthcare space so everyone can access the right care at the right time. Rahul worked on building up Arc Health, a digital technology business and helped grow Medicspot’s primary healthcare business.
He holds an MBA from London Business School and a Chemical Engineering degree from Indian Institute of Technology, Delhi.
Hologic Inc
Country Business Manager - Diagnostics UK and Ireland
As the Diagnostics Country Manager for Hologic, I lead the UKI diagnostics division in Women’s Health, driving commercial strategy, market growth, and innovation in the molecular diagnostics sector. With extensive experience in marketing, sales, and leadership, I have navigated the challenges of bringing cutting-edge diagnostic solutions to market, working closely with healthcare providers, policymakers, and industry stakeholders.
My career spans businesses of all sizes—from SMEs to large multinational primary managed service organizations—giving me a broad perspective on the diverse needs of the in vitro diagnostics (IVD) industry. I have a strong track record in developing and executing commercial strategies, leading high-performing teams, and fostering key industry partnerships to ensure sustainable growth and improved patient outcomes.
My ethos and vision is on innovation, driving change and thought leadership. I believe in the question ‘How can we make this happen’ to drive new ways of thinking.
In the fast-paced, competitive and evolving healthcare sector, securing funding for innovative ideas is a challenge. Understanding what investors value is key to successfully attracting funding and turning ideas into reality. What are investors looking for in HealthTech entrepreneurs, and how can you effectively capture their interest?
Praetura Ventures
Investment Director
Sim has worked in the financial services industry for over 17 years, including for leading firms such as AIG. With a CV spanning banking, real estate, finance, investments, pensions and funds, Sim knows the value more than money can have for founders and companies and delivers on this promise every day.
Her responsibilities include financial and qualitative appraisals, marketing, due diligence, project management and client relationship management.
TBAT Innovation Ltd
Director
After establishing TBAT in 2002 as a consultancy catering to the SME sector, Sam led the company’s evolution into the innovation-centric enterprise it is today. TBAT now specializes in supporting companies throughout the entire new product and process innovation cycle. Sam began his career as a graduate and manufacturing engineer at Rolls-Royce Aerospace before transitioning to Rolls Royce and Associates as a Development and Project Engineer. Currently, Sam heads up the Business Development and R&D Tax Credits side of the business.
MyMeno
Angel Investor
Nick is an angel investor in MyMeno. He has a portfolio of advisory board roles working alongside founders in FemHealth, FinTech and GreenTech. He is also an accredited coach and mentor working with senior executives and business founders in periods of change. Nick is a former senior partner and head of debt advisory for KPMG in the UK. He has over 25 years of experience in the corporate finance market, spanning fund raising, mergers and acquisitions and capital advisory. He has advised on c£5bn of financing throughout his career. He has been both a CFO and CEO leading businesses through organisational change
Maxwellia
Chief Financial Officer
Candice, an FCCA-qualified powerhouse, brings her sharp financial savvy and strategic expertise to the Maxwellia team. A wizard with cash flow forecasting, financial controls, and budgeting, she’s got the numbers game mastered.
With a track record of driving growth and streamlining operations, Candice knows how to make businesses thrive. Her deep experience in manufacturing and consumer brand commercialisation perfectly positions her to fuel Maxwellia’s mission of innovating and expanding in the healthcare world. When it comes to building a bright financial future, Candice is the one to watch.
Microplate Dx
Chief Executive Officer & Co-founder
Dr Stuart Hannah is a health technology entrepreneur on a mission to transform the lives of patients globally by developing rapid diagnostic tests to tackle antimicrobial resistance. He co-founded Microplate Dx with the vision to become the leading provider of platform diagnostics to tackle the major global healthcare challenge of antimicrobial resistance in a rapid, scalable and inclusive manner. Dr Hannah has a PhD in Electronic & Electrical Engineering from the University of Strathclyde in Glasgow, Scotland, and has 10+ years’ academic and industrial experience in developing biosensors and diagnostics for healthcare. Since forming the company in 2021 and being awarded a prestigious Royal Society of Edinburgh Enterprise Fellowship, Stuart has already raised substantial equity investment and grant funding for Microplate Dx and won several significant awards for his work.
HealthTech is truly multidisciplinary, requiring expertise in fields like health, biology, chemistry, technology, engineering, and computing. How can we cultivate a collaborative ecosystem that nurtures innovation while developing the skills necessary for interdisciplinary success?
Kimal
Chief Executive Officer
Matt has been in the healthcare sector since 2015 after a 15 year career working in private equity and banking. Prior to joining the healthcare sector Matt worked for a range of investment companies with different portfolio focusses from UK real estate through to consumer goods businesses in Sub-Saharan Africa.
Matt joined Kimal in 2015 initially as Corporate Development Director to oversee two strategic projects for the business, namely the construction, start up and accreditation of its first non-UK manufacturing facility and the construction of its new global logistics hub in the UK. Matt took over as Kimal’s CEO in early 2020 where his aim was to bring a refreshed focus on product diversification, continued evolution of its manufacturing capabilities and leveraging of its enhanced asset base. Matt also sits on the ABHI Board.
Kathryn Simpson Consulting Limited
Business Consultant
Kathryn is a respected and successful change leadership expert, with diverse career experience in Europe and North America. She has over 25 years of consulting and line experience with leading organisations (Unilever, Mars, KPMG and GSK). Since 2007 she has been leading her own independent consulting business, primarily working within the Life Sciences sector. By partnering with leaders at all levels within the sector, growth and sustainable success has resulted for the organisations she has worked with. She has recently published a book – “Leading for Change: How to thrive during uncertain times”.
She provides each organisation the approaches they need to meet their unique situation. Tailored approaches are used to develop a consolidated understanding of their environment and the priority challenges they face. This provides the basis for facilitating customised workshops where leaders not only create a desired future, but are ready to move forward and implement their ideas. Working with individual leaders or teams she advises how to bring other stakeholders with them so they achieve success together. These practical and supportive approaches create focus, accountability and collaboration across organisations and their partners. Organisations are left with an increased leadership capability and tangible business results.
Decently
Co-founder
Leads on: Working with our clinical partners to shape and manage our product roadmap for Melo, whilst leading our Product team.
Before Decently: 8yrs in HealthTech building products and leading R&D projects with the NHS, charities & academia. Founding MD of an award winning digital health startup focussed on falls prevention & fellow of the NHS Digital Health Accelerator.
Lucid Group
Managing Director
I lead a team of usability, compliance, engineering, design and manufacturing specialists at Lucid. We create, prototype and deliver innovative products and digital interactions, for health, personal care and scientific markets.
My focus is on developing great product experiences, compliant with complex regulatory constraints.
Lucid is accredited to ISO 13485 for medical device design and manufacturing. Most of our work involves wireless comms, intuitive digital user interfaces, electronics and mechanical development. Outside of healthcare we apply the same skills to other compliance constrained fields such as ATEX/ICEX devices, security systems, to cosmetic rejuvenation products, toys and games.
Lucid’s team can help clients to source production, manage statutory test and product delivery. Much of our work is spotting and planning the development of early stage opportunities, particularly for VCs and Universities. We make product for usability evaluation, clinical investigations and batch production, with facilities to 3D print, laser cut, mould, test and assemble in house.
I’ve collected a broad skill set over 30 years of working in product development. I’m an MBA graduate, a Chartered Engineer, a member of the Institute of Engineering Designers and have been a board member of the British Industrial Design Association.
B Braun UK
Head of Value and Access
A B Braun stalwart of over 23 years, Mike has spent his career in a variety of commercial roles at B Braun Medical UK across Medical Devices, Clinical Nutrition & Pharma.
He now has a wider remit across B Braun, as Head of Value & Access, which includes responsibilities for Government Affairs & Market Access. A passionate supporter of Value Based Healthcare, Mike is the ABHI Commercial Group Chair and is also on the board of the British Specialist Nutrition Association and a mentor on the NHS Clinical Entrepreneur Program.
A brand-new addition to the Integrates conference, this session will highlight the latest R&D breakthroughs from both industry and academia in the HealthTech field. Through a series of dynamic, short presentations, attendees will hear from emerging innovators and gain insights into new technologies while exploring the latest trends shaping the future of healthcare and life sciences.
UKRI Science and Technology Facilities Council
Head of Clusters (NW)
For the last couple of years Phil has had the pleasure of working with colleagues and stakeholders in developing High-Tech. regional innovation clusters, in key strategic sectors for the UK. This includes setting up and leading the North West of England’s Health and Life sciences Cluster (HealthTech) and establishing other clusters in sectors such as Space.
The clusters exist to connect key capabilities between stakeholders, national science facilities and innovators in the wider ecosystem to support collaboration, cross-sector innovation and community building.
A scientist by background, he undertook a PhD for the European Space Agency at King’s College London, conducting numerous studies on a SkinSuit which was designed to support astronauts in space and reduce the risk of spinal issues post flight. This has subsequently been used on several astronaut missions.
Passionate about cross sector opportunities, including Health & Space, for 5 years he coordinated the UK’s Space Life and Biomedical Science Association, which among other core activities he led the development of the UK Position Paper ‘Why Space? The opportunity for Health & Life Science Innovation”. He currently chairs the UK’s Regional Space Cluster Advisory board and at a European Level serves as the elected President for the European Low Gravity Research Association (ELGRA).
Digital therapeutics provide accessible, effective, and affordable support or treatment options. With mental health apps leading the charge, these digital platforms are transforming how individuals manage their health and wellbeing. Can these digital tools create a more inclusive, accessible care system for both physical and mental health?
ABHI
Digital Health Lead
Andrew is responsible for working with partners to ensure that the UK maximises the opportunities for citizen health and economic wealth by appropriate investment in data driven healthcare.
A vital element of this is building on the unique opportunities delivered by the NHS to enable industry to access robust, well curated data within a strong ethical framework. Coupled with close engagement with national bodies to evolve regulatory and reimbursement systems the aim is to create a strong infrastructure and commercial environment that can support the development and wide-spread adoption of the best HealthTech solutions.
Andrew has over 25 years experience in the medical technology sector having worked within MedTech divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development across both capital and consumable equipment.
He has a degree in Applied Physics and a post graduate diploma in marketing.
Speek Health
Co-founder & CEO
Kanu is the Co-Founder and CEO of Speek Health, a mental health platform that equips parents with skills, knowledge and community to break the cycle of teenage self-harm. Prior, she co-founded a diagnostics startup based out of Singapore with a proprietary MedTech solution to simplify sample collection for diagnostics. Kanu has worked with start-ups and corporations (17+ years experience working in HealthTech). She has managed multiple programs, projects and people in the digital health space based out of India, UK, US and Singapore at International SOS, world’s leading healthcare services firm. Trained as a biotechnologist and then studied Management at the LSE. Fierce about diversity at the workplace, and on the side learning pottery.
Clinology
Chief Executive Officer
A highly experienced clinical research leader with a proven track record in scaling and optimizing CROs, Site Management Organizations (SMOs), and clinical trial networks. Extensive expertise in developing and implementing growth strategies, operational efficiencies, and business transformation initiatives across global research landscapes.
Innovate UK
Innovation Lead | Healthy Lives | Mindset Programme
Jane Guest currently leads the £20m Mindset Programme at Innovate UK. From an academic background in Cognitive Psychology and Computing Science, through to inventing and innovating in healthcare and providing strategic marketing consultancy to technology clients as an SME founder, she is passionate about the potential impact that digital mental health can have on society and the economy.
MD Healthcare
Patient Engagement Pioneer
Mark Duman MRPharmS is a clinician, management consultant, and patient advocate who works with organisations to improve their products and services primarily by unlocking the full potential of patient and public engagement. With this in mind, he designed and applies the iLLUMiNATE Tool to help life sciences companies optimise their patient engagement efforts. Notable achievements include installing a Cerner Electronic Health Record in Scotland in 1994 and developing the award-winning PharmAssist system at Lewisham NHS Hospital assisting ethnic minorities with their medicines-taking. At The King’s Fund, he advanced shared clinical decision-making by co-founding the Patient Information Forum and through authoring their best-selling publication to date, ‘Producing Patient Information.’ His career spans roles at the BBC, where he created behavioural health interventions, and consulting for life sciences, digital health and public sector clients including Pfizer, Siemens Healthineers, Microsoft, Innovate UK & NHS England. Mark holds various ‘expert patient’ roles including an Ambassador for NHS England’s Personalised Care Institute and sits on Diabetes UK’s Strategy & Research Group. He is a Non-Executive Director for Quiddity Health and the NHS Advancing Quality Alliance (Aqua) and Entrepreneur in Residence (HealthTech) for the Turing Innovation Catalyst.
Bruntwood SciTech
Bright Building
This year we have an exciting addition to HealthTech Integrates – the Future Lab Mixer!
From 4pm you can enjoy some further networking opportunities, drinks and entertainment, courtesy of Bruntwood SciTech and the Bright Building.
This will be in the same conference space and you are invited to attend as part of the event.
For further information and to book your place please click here. We look forward to extending the day with you!
The Bright Building sits at the heart of Manchester Science Park, providing a state-of-the-art hub for businesses to come together, socialise, and collaborate. It’s already the home of several world-leading digital and tech businesses and is a ‘living lab’ technology testbed using a Tesla Powerpack battery to power the building.
Located next door to the University of Manchester and the UK’s largest NHS Trust, the Bright Building offers affordable, high spec office space with flexible leases, as well as the support your business needs to scale and grow.
Bruntwood SciTech is the country’s leading developer of city-wide innovation ecosystems, and the largest dedicated property platform for the UK knowledge economy. Alongside a 50-year track record in the property industry, we bring a wealth of experience in creating and developing strategic partnerships with UK regional cities, universities and NHS Trusts.
Offering premium office and lab space, a range of scientific services and specialist business support, we are perfectly placed to help companies – particularly those in the science and technology sectors – to form, scale and grow.
The Bright Building is located in Manchester Science Park. Situated just off Oxford Road, the Park is easily accessible by both public transport and car, with a public car park available on Denmark Road.
Bright Building, Manchester Science Park, Pencroft Way, M15 6GZ
